Antiplatelet therapy in secondary stroke prevention

By Crawford K Michelle   Talbert Robert L  

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 10, 2001-10 ,pp. : 1609-1613

Informa Healthcare

Access to resources Recommend Favorite

Risk Reduction Strategies in Ischaemic Stroke: The Role of Antiplatelet Therapy

By Alberts M.J.  

Clinical Drug Investigation, Vol. 24, Iss. 5, 2004-01 ,pp. : 245-254

Adis International

Access to resources Recommend Favorite

Cost-Effectiveness Analysis of Antiplatelet Therapy in the Prevention of Recurrent Stroke in the UK: Aspirin, Dipyridamole and Aspirin-Dipyridamole

By Chambers M.  

PharmacoEconomics, Vol. 16, Iss. 5, 1999-11 ,pp. : 577-593

Adis International

Access to resources Recommend Favorite

Advances in Antiplatelet Therapy for Stroke Prevention: the New P2Y12 antagonists

By  

Current Drug Targets, Vol. 11, Iss. 3, 2010-03 ,pp. : 380-391

Bentham Science Publishers

Access to resources Recommend Favorite

Prasugrel versus Clopidogrel Antiplatelet Therapy after Acute Coronary Syndrome: Matching Treatments with Patients

By Tcheng James E.  

American Journal of Cardiovascular Drugs, Vol. 12, Iss. 2, 2012-04 ,pp. : 83-91

Adis International

Access to resources Recommend Favorite